Knight Therapeutics's total assets for Q3 2024 were C$962.29M, an increase of 1.79% from the previous quarter. KHTRF total liabilities were C$188.38M for the fiscal quarter, a 3.19% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.